International Medical Q10 Congress held in Prague - 23.09.2008

    International Medical Q10 Congress held in Prague

    Once again, Pharma Nord teamed up with the International Coenzyme Q10 Association to present the latest medical sciences about Q10 to a large number of doctors, pharmacists and other health professionals. The congress drew more than 600 visitors from all over the world.

    More than 600 general practitioners, internists, cardiologists and pharmacists gathered at the Marriott Hotel in Prague on September 13th, to catch up on the latest scientific research about coenzyme Q10. The occasion was the International Medical CoQ10 Congress held by the International CoQ10 Association and Pharma Nord Academy. Among the speakers were some of the worlds foremost experts on coenzyme Q10, who had come from Italy, Denmark, Slovakia, Australia and the United States to share their findings with the assembled medical professionals. The congress was supported by the Czech Chambers of Physicians and Pharmacists, and many local and visiting doctors and pharmacists used it as an opportunity to get up to date on Q10.

    "It was a great pleasure to see the large number of medical professionals who chose to participate. The scientific research on Q10 continues to yield exciting results, but if this new knowledge is to have an impact on the life quality and health of the broad population, it is very important that those results are communicated to as many doctors and pharmacists as possible," says technical director of Pharma Nord Sven Moesgaard.

    The congress was opened by the President of the International Coenzyme Q10 Association professor G.P. Littaru, who gave a presentation on the importance of Q10 in medical practice. After this introduction, other members of the IQA presented the latest findings from the ongoing Q10 research. Among these were several very interesting results from studies regarding the use of Q10 to prevent the side effects of statin treatment, as well as an update on the large multi-center Q-SYMBIO study, which examines the use of Q10 to treat patients with chronic heart failure.

    Lectures were also given on Q10 as an antihypertensive agent and the use of Q10 in a cardiac wellness program in Australia. Apart form a large number of Czech medical professionals, the audience contained participants from Slovakia, Hungary, UK, Turkey, Spain, Thailand, the Ukraine and Japan.